Abstract
We evaluated and described the impact of prostatic indocyanine green (ICG) injection on extended pelvic lymph node (LN) dissection (ePLND) in robotic-assisted radical prostatectomy (RARP). Between January 2019 and December 2021, we included consecutive 50 PCa patients who underwent ePLND during RARP with (n = 25) or without (n = 25) prostatic ICG injection. ICG injection was performed during abdominal port placement and robot docking. Pelvic LNs reflecting green color were initially excised and then the template was completed. The outcomes of two groups were compared. Overall, nine (36%) and five (20%) of the patients had metastatic LN involvement in the ICG and non-ICG groups, respectıvely. Of the 509 dissected LNs in the ICG group, 122 (23.9%) were fluorescence active. 20 LNs (3.9%) were metastatic in this group, 9 (45%) of which were ICG+. 408 LNs were resected on the non-ICG group with 8(1.9%) being metastatic. Eight (88.9%) of nine pN+ patients were florescent positive in the ICG group. Out of six patients with pN+ disease, Ga68 PSMA-PET/CT detected positive LNs preoperatively. In addition to preoperative Ga68 PSMA-PET/CT investigation, ICG-guided ePLND might increase identification and removal of metastatic LNs duirng RARP. Improvements ın stagıng and oncologıc outcomes may also be seen ın intermediate- and high-risk patients.
Similar content being viewed by others
References
Weckermann D, Dorn R, Trefz M et al (2007) Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients. J Urol 177:916
Maurer T, Gschwend JE, Rauscher I, Souvatzoglou M, Haller B, Weirich G et al (2016) Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer. J Urol 195(5):1436–1443
Esen T, Falay O, Tarim K et al (2021) 68Ga-PSMA-11 positron emission tomography/computed tomography for primary lymph node staging before radical prostatectomy: central review of imaging and comparison with histopathology of extended lymphadenectomy. Eur Urol Focus 7(2):288–293
Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R et al (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307–1317
Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553
Van der Poel HG, Buckle T, Brouwer OR et al (2011) Intraoperative laparoscopic fluorescence guidance to the sentinel lymph node in prostate cancer patients: clinical proof of concept of an integrated functional imaging approach using a multimodal tracer. Eur Urol 60(4):826–833
Jeschke S, Lusuardi L, Myatt A et al (2012) Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging. Urology 80:1080
Nair R, Aggarwal R, Khanna D (2011) Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum 41(2):95–105
Cacciamani GE, Shakir A, Tafuri A, Gill K, Han J, Ahmadi N et al (2020) Best practices in near-infrared fluorescence imaging with indocyanine green (NIRF/ICG)-guided robotic urologic surgery: a systematic review-based expert consensus. World J Urol 38(4):883–896
Abdollah F, Gandaglia G, Suardi N, Capitanio U, Salonia A, Nini A et al (2015) More extensive pelvic lymph node dissection improves survival in patients with node-positive prostate cancer. Eur Urol 67(2):212–219
Seiler R, Studer UE, Tschan K et al (2014) Removal of limited nodal disease in patients undergoing radical prostatectomy: long term results confirm a chance for cure. J Urol 191:1280
Mazzone E, Dell’Oglio P, Grivas N, Wit E, Donswijk M, Briganti A et al (2021) Diagnostic value, oncological outcomes and safety profile of image-guided surgery technologies during robot-assisted lymph node dissection with sentinel node biopsy for prostate cancer. J Nucl Med 62(10):1363–1371
Wit EMK, Acar C, Grivas N, Yuan C, Horenblas S, Liedberg F et al (2017) Sentinel node procedure in prostate cancer: a systematic review to assess diagnostic accuracy. Eur Urol 71(4):596–605
Nguyen DP, Huber PM, Metzger TA, Genitsch V, Schudel HH, Thalmann GN (2016) A specific mapping study using fluorescence sentinel lymph node detection in patients with intermediate- and high-risk prostate cancer undergoing extended pelvic lymph node dissection. Eur Urol 70(5):734–737
Yuen K, Miura T, Sakai I et al (2015) Intraoperative fluorescence imaging for detection of sentinel lymph nodes and lymphatic vessels during open prostatectomy using indocyanine green. J Urol 194:371–377
Hruby S, Englberger C, Lusuardi L, Schätz T, Kunit T, Abdel-Aal AM et al (2015) Fluorescence guided targeted pelvic lymph node dissection for intermediate and high risk prostate cancer. J Urol 194:357–363
Harke NN, Godes M, Wagner C, Addali M, Fangmeyer B, Urbanova K et al (2018) Fluorescence-supported lymphography and extended pelvic lymph node dissection in robot-assisted radical prostatectomy: a prospective, randomized trial. World J Urol 36(11):1817–1823
Manny TB, Patel M, Hemal AK (2014) Fluorescence-enhanced robotic radical prostatectomy using real-time lymphangiography and tissue marking with percutaneous injection of unconjugated indocyanine green: the initial clinical experience in 50 patients. Eur Urol 65(6):1162–1168
Mohler JL, Antonarakis ES, Armstrong AJ, D’Amico AV, Davis BJ, Dorff T et al (2019) Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 17(5):479–505
Funding
The authors declare that this study has received no financial support.
Author information
Authors and Affiliations
Contributions
Surgical and medical practices—AEC, BEÇ, AA, İK, DEB, FF, AÖ; concept—AEC, MDB, YK, TE; design—AÖ, AEC, TE; data collection and/or processing—AÖ, BEÇ, İK, AA, DEB, FOF; analysis and/or interpretation—KT, AFS, EB; literature search—AÖ, İCA; writing—AÖ, TE.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Preliminary part of this work received a 2nd Best Poster Prize during ERUS-DRUS21 Meeting, 11–13 November 2021, Dusseldorf, Germany.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1ICG guided extended pelvic lymph node dissection during robot assisted radical prostatectomy (MP4 1667269 kb)
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Özkan, A., Köseoğlu, E., Canda, A.E. et al. Fluorescence-guided extended pelvic lymphadenectomy during robotic radical prostatectomy. J Robotic Surg 17, 885–890 (2023). https://doi.org/10.1007/s11701-022-01480-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11701-022-01480-z